Ignite Creation Date:
2025-12-25 @ 2:09 AM
Ignite Modification Date:
2026-02-11 @ 7:39 AM
Study NCT ID:
NCT03516760
Status:
TERMINATED
Last Update Posted:
2022-09-29
First Post:
2018-04-06
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Dose-escalating Phase I Trial With GEM333 in Patients With Acute Myeloid Leukemia
Sponsor:
AvenCell Europe GmbH
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2018-04-11
Start Date Type:
ACTUAL
Primary Completion Date:
2022-06-14
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-06-14
Completion Date Type:
ACTUAL
First Submit Date:
2018-04-06
First Submit QC Date:
None
Study First Post Date:
2018-05-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-09-28
Last Update Post Date:
2022-09-29
Last Update Post Date Type:
ACTUAL